None listed
Conditions
Brief summary
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment Who is it for? You may be eligible for this study if you are an adult male with prostate cancer. Study details All participants in this study will attend a single one-hour interview which will explore their thoughts regarding the risk of side effects from treatment and will include a choice experiment. This choice experiment will involve the participant making a series of decisions based on particular scenarios. It is hoped this study will help explore the trade-offs patients are willing to make between breast-related side effects, other quality of life (QOL) impacts and cancer control. Note: this brief summary is intended for lay audience.
Interventions
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment. Interviews will be conducted by qualified study staff, with qualitative input being recorded over approximately 1 hour.
Sponsors
St Vincents Hospital Sydney
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Men with high-risk biochemically recurrent prostate cancer but no androgen deprivation treatment +/- androgen receptor pathway inhibitor experience. OR • Men with androgen deprivation treatment +/- androgen receptor pathway inhibitor experience who have experienced breast-related side effects from this treatment.
Exclusion criteria
Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.
Outcome results
None listed